INS and type 1 diabetes mellitus: A total of 67% of patients (n = 12) with type 1 diabetes did not adjust their basal insulin when they became unable to eat due to chemotherapy side effects, deliberately skipped doses because of misunderstanding how to manage insulin during illness or failed to seek medical advice as their glucose control worsened prior to hospitalization.